Meyka Pro banner
InSilico Medicine Cayman TopCo

InSilico Medicine Cayman TopCo (3696.HK) Stock Competitors & Peer Comparison

See (3696.HK) competitors and their performances in Stock Market.

3696.HKHKSE
TechnologySoftware - Infrastructure
HK$45.90
HK$1.32(2.96%)
Hong Kong Market is Open · 14:18

Peer Comparison Table: Software - Infrastructure Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
3696.HKHK$43.20-11.87%25B-1.23-HK$35.11N/A
4338.HKHK$1,600.00N/A24.7T12.98HK$123.28+1.74%
0100.HKHK$216.00-15.63%67.7B-48.54-HK$4.45N/A
2718.HKHK$110.30-16.06%18.5B-0.69-HK$159.27N/A
2706.HKHK$35.00-10.07%14B-159.09-HK$0.22N/A
1956.HKHK$64.60-15.72%11.2B-53.82-HK$1.20N/A
2391.HKHK$14.01-1.27%7.6B17.96HK$0.78N/A
2598.HKHK$4.24-3.64%6.6B26.51HK$0.16N/A
9678.HKHK$65.80-9.92%4.7B-12.21-HK$5.39N/A
6608.HKHK$4.82-5.12%3.9B6.48HK$0.74N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

3696.HK vs 4338.HK Comparison July 2026

3696.HK plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 3696.HK stands at 25B. In comparison, 4338.HK has a market cap of 24.7T. Regarding current trading prices, 3696.HK is priced at HK$43.20, while 4338.HK trades at HK$1,600.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

3696.HK currently has a P/E ratio of -1.23, whereas 4338.HK's P/E ratio is 12.98. In terms of profitability, 3696.HK's ROE is N/A, compared to 4338.HK's ROE of +0.33%. Regarding short-term risk, 3696.HK is more volatile compared to 4338.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3696.HK.Check 4338.HK's competition here

Stock price comparison of stocks in the Technology Sector

Loading...

Frequently Asked Questions